The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Emergent BioSolutions has a sound turnaround strategy in place that is producing positive results. Emergent BioSolutions' cost-cutting efforts have the company on track for profitability in 2025. The ...
Emergent BioSolutions delivered a strong Q2 2025, beating its own guidance and showing major improvements in margins. EBS has a sound turnaround strategy that is showing signs of success. The company ...
EBS is trading in the middle of its 52-week range and below its 200-day simple moving average. Price change The price of EBS shares has increased $0.42 since the market last closed. This is a 5.10% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results